KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Exchange Rate Effect: 2013-2024

Historic Exchange Rate Effect for Novavax (NVAX) over the last 12 years, with Dec 2024 value amounting to -$7.8 million.

  • Novavax's Exchange Rate Effect fell 89.08% to $658,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 152.85%. This contributed to the annual value of -$7.8 million for FY2024, which is 338.39% down from last year.
  • As of FY2024, Novavax's Exchange Rate Effect stood at -$7.8 million, which was down 338.39% from $3.3 million recorded in FY2023.
  • Over the past 5 years, Novavax's Exchange Rate Effect peaked at $4.5 million during FY2022, and registered a low of -$7.8 million during FY2024.
  • Over the past 3 years, Novavax's median Exchange Rate Effect value was $3.3 million (recorded in 2023), while the average stood at -$2,667.
  • As far as peak fluctuations go, Novavax's Exchange Rate Effect surged by 6,709.38% in 2020, and later crashed by 350.21% in 2021.
  • Novavax's Exchange Rate Effect (Yearly) stood at $2.1 million in 2020, then slumped by 350.21% to -$5.3 million in 2021, then spiked by 185.41% to $4.5 million in 2022, then declined by 27.61% to $3.3 million in 2023, then tumbled by 338.39% to -$7.8 million in 2024.